微细胞和干细胞用于缺血性中风治疗 - 机制,当前状态和治疗挑战
Aleksandra Markowska1, Dariusz Koziorowski1, Stanisław Szlufik1
1Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, 03-242 Warsaw, Poland.
Frontiers in bioscience (Landmark edition)
|November 2, 2023
概括
使用微质细胞和干细胞的神经保护疗法在缺血性中风方面表现有前途. 像Muse细胞和外体细胞疗法这样的新方法比传统治疗方法提供了优势,解决了目前的局限性.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 缺血性中风是全球死亡和残疾的主要原因.
- 目前的再注血疗法存在重大局限性.
- 研究正在探索涉及微质细胞和干细胞的神经保护策略.
研究的目的:
- 审查预先条件化的微质和干细胞衍生的细胞外囊泡的治疗效果.
- 阐明作用机制,包括旁观者效应,外体分泌和生物桥形成.
- 讨论临床前和临床发现,挑战和干细胞治疗的潜在解决方案.
主要方法:
- 审查关于微质细胞和干细胞治疗缺血性中风的现有文献.
- 对神经发生,血管发生,细胞迁移和神经炎症调节等机制的分析.
- 检查基于外体的疗法和新型干细胞类型,如Muse细胞.
主要成果:
- 干细胞 (MSC,NSC,iPSC,Muse细胞) 和微质细胞显示出神经保护的潜力.
- 外基因组疗法比细胞疗法具有优势,包括较低的免疫性和易于存储.
- 临床前研究显示有希望,但临床翻译面临挑战.
结论:
- 微细胞和干细胞衍生因素,特别是外体细胞,代表了缺血性中风的有希望的治疗途径.
- 慕斯细胞提供了一种新的方法,绕过了传统干细胞的限制.
- 需要进一步的研究和创新策略来克服神经保护中的临床翻译挑战.
相关概念视频
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...